Erratum

This article refers to:

The Prevalence of Age-Related Macular Degeneration in Italy (PAMDI) Study: Report 1

An error occurred in the article entitled “The Prevalence of Age-related Macular Degeneration in Italy (PAMDI) Study: Report 1” on pages 129–136 in issue 18(03) of Ophthalmic Epidemiology:

There were conversion errors in Table 3. The table is reproduced below in its correct format.

We apologize for this serious error.

Table 3  Prevalence of age-related macular degeneration in Northeast Italy.

Age range (years)	Gender	Urban		Rural		All
		Cases/Sample	Standardized prevalence rate (95% CI)	Cases/Sample	Standardized prevalence rate (95% CI)	Cases/Sample	Standardized prevalence rate (95% CI)
Any ARMD
61−64		34/79	45.2 (33.6–56.7)	39/66	59.1 (47.2–70.9)	73/145	53.5 (45.0–61.9)
65−69		56/121	46.1 (37.9–54.3)	67/123	56.4 (47.6–65.1)	123/244	52.2 (46.0–58.4)
70−74		50/86	57.8 (47.1–68.5)	70/102	68.8 (59.6–78.0)	120 /188	64.0 (57.0–71.0)
75−79		64/89	72.0 (62.6–81.4)	48/61	80.3 (70.1–90.6)	112/150	76.6 (69.5–83.6)
80+		34/45	77.1 (63.5–90.8)	47/73	66.0 (55.2–76.9)	81/118	71.1 (62.9–80.4)
All ages	Total	238/420	59.8^a (54.8–64.7)	271/425	65.0^a (60.4–69.6)	509/845	62.7 (59.3–66.1)
	Men	89/173	53.3 (45.5–61.2)	128/215	60.0 (53.3–66.7)	217/388	57.2^e (52.1–62.4)
	Women	149/247	64.0 (57.5–70.5)	143/210	68.9 (62.6–75.3)	292/457	66.7^e (62.2–71.2)
ARM1
61−64		30/79	41.1 (29.5–52.6)	35/66	53.0 (41.2–64.9)	65/145	48.2 (39.7–56.6)
65−69		47/121	38.4 (30.1–46.7)	58/123	48.7 (39.8–57.5)	105/244	44.5 (38.2–50.8)
70−74		39/86	45.3 (34.6–56.1)	55/102	53.8 (43.8–63.7)	94/188	50.1 (42.8–57.4)
75−79		49/89	55.2 (44.7–65.7)	38/61	61.9 (49.2–74.7)	87 /150	58.9 (50.4–67.4)
80+		22/45	47.2 (34.0–60.4)	26/73	37.0 (25.9–48.1)	48/118	42.2 (33.6–50.8)
All ages	Total	187/420	45.1^b (39.7–50.5)	212/425	50.7^b (45.8–55.6)	399/845	48.3 (44.6–51.9)
	Men	70/173	42.7 (35.4–49.9)	109/215	52.0 (45.1–58.9)	179/388	48.1^f (42.9–53.3)
	Women	117/247	46.7 (39.7–53.7)	103/210	49.7 (42.8–56.5)	220/457	48.3^f (43.3–53.3)
ARM2
61−64		3/79	3.1 (0.0–6.5)	3/66	4.5 (0.0–9.6)	6/145	3.9 (0.6–7.3)
65−69		4/121	3.4 (0.2–6.6)	7/123	5.7 (1.5–9.9)	11/244	4.8 (1.9–7.6)
70−74		6/86	6.8 (1.4–12.1)	14/102	14.2 (7.1–21.2)	20/188	11.0 (6.3–15.6)
75−79		12/89	13.4 (6.4–20.5)	9/61	16.3 (6.7–26.0)	21/150	15.0 (8.8–21.2)
80+		7/45	15.9 (5.6–26.3)	16/73	22.3 (12.2–32.4)	23/118	19.1 (11.8–26.3)
All ages	Total	32/420	8.6^c (5.3–11.9)	49/425	11.8^c (8.6–14.9)	81/845	10.4 (8.1–12.7)
	Men	12/173	6.7 (3.0–10.4)	17/215	7.2 (3.9–10.6)	29/388	7.0^g (4.5–9.5)
	Women	20/247	9.8 (5.4–14.2)	32/210	15.4 (10.4–20.3)	52/457	12.8^g (9.3–16.3)
AMD
61−64		1/79	1.0 (0.0–3.0)	1/66	1.5 (0.0–4.5)	2/145	1.3 (0.0–3.3)
65−69		5/121	4.3 (0.6–8.1)	2/123	2.0 (0.0–4.7)	7/244	2.9 (0.7–5.2)
70−74		5/86	5.7 (0.8–10.6)	1/102	0.9 (0.0–2.7)	6/188	3.0 (0.6–5.3)
75−79		3/89	3.4 (0.0–7.1)	1/61	2.1 (0.0–6.2)	4/150	2.7 (0.0–5.5)
80+		5/45	14.0 (3.1–25.0)	5/73	6.7 (0.6–12.8)	10/118	10.4 (4.1–16.7)
All ages	Total	19/420	6.0^d (2.9–9.2)	10/425	2.5^d (0.9–4.1)	29/845	4.1 (2.4–5.7)
	GA					11/845	1.61 (0.54–2.68)
	CNV					17/845	2.10 (0.97–3.23)
	PED					1/845	0.36 (0.00–1.06)
	Men	7/173	3.9 (1.0–6.8)	2/215	0.8 (0.0–1.8)	9/388	2.1^h (0.7–3.4)
	GA					4/388	0.90 (0.02–1.79)
	CNV					5/388	1.17 (0.13–2.21)
	PED					0/388	-
	Women	12/247	7.4 (3.1–11.8)	8/210	3.9 (1.2–6.6)	20/457	5.5^h (2.8–8.2)
	GA					7/457	213 (0.40–3.85)
	CNV					12/457	2.78 (0.97–4.59)
	PED					1/457	0.62 (0.00–1.84)

GA=Geographic atrophy; CNV= choroidal neovascularization; PED=pigment epithelial detachment

Comparison of gender- and age-adjusted prevalence rates between areas of residence, Cochran-Mantel-Haenszel statistics: ^aCMH = 5.7, P = 0.017; ^bCMH = 3.9, P = 0.048; ^cCMH = 3.5, P = 0.061; ^dCMH = 4.2, P = 0.040

Comparison of area- and age-adjusted prevalence rates between genders, Cochran-Mantel-Haenszel statistics: ^eCMH = 4.9, P = 0.027; ^fCMH = 0.6, P = 0.447; ^gCMH = 2.7, P = 0.102; ^hCMH = 1.4, P = 0.241